Werum IT's Welf Ludwig and Immatics Biotechnologies, Ali Mohamed discuss the difficulties surrounding manufacturing CAR-T cell therapies. 

Ahead of the CAR-T congress on April 16th - 17th in Boston, we spoke with Welf Ludwig, Werum IT Solutions (Lüneburg, Germany), and Ali Mohamed, Immatics Biotechnologies (Tuebingen, Germany), to see how they are tackling manufacturing and scalability challenges. Continue the conversation on manufacturing and meet with both speakers at the CAR-T Congress USA. 

 Visit www.car-tcongress.com for the full agenda and to register to attend. Alternatively, contact Georgia Durham for more details at: events@kisacoresearch.com